JCM
GNOM icon

Jacobi Capital Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Jacobi Capital Management’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,044
Closed -$92K – 762
2021
Q3 		$92K Hold
1,044
– – 0.01% 531
2021
Q2 		$104K Buy
1,044
+275
+36% +$24.4K 0.01% 484
2021
Q1 		$69K Buy
769
+344
+81% +$34K 0.01% 513
2020
Q4 		$40K Buy
425
+312
+276% +$26.1K 0.01% 575
2020
Q3 		$8K Buy
+113
New +$8.1K ﹤0.01% 852

Other funds holding GNOM

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $12.4B AUM 29.42% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Jacobi Capital Management's GNOM Position: Q4 2021 in Review

Jacobi Capital Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2021, closing a stake of 1,044 shares — an estimated $92K sold.

Jacobi Capital Management first reported a position in GNOM in Q3 2020 and held it in 5 quarters. The position peaked at $104K in Q2 2021. 61 funds tracked by Wall St. Rank hold GNOM as of Q4 2021.

  • Jacobi Capital Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 1,044 Global X Genomics & Biotechnology ETF shares in Q4 2021, an estimated $92K.
  • Jacobi Capital Management first reported a position in Global X Genomics & Biotechnology ETF in Q3 2020 and held it in 5 quarters.
  • Jacobi Capital Management's Global X Genomics & Biotechnology ETF position peaked at $104K in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.